These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25293387)

  • 41. Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study.
    Kameda R; Nomoto H; Cho KY; Kawata S; Omori K; Takeuchi J; Nagai S; Kurihara Y; Aoki S; Nakamura A; Atsumi T; Miyoshi H
    BMJ Open; 2020 Feb; 10(2):e034883. PubMed ID: 32034028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study.
    Idorn T; Knop FK; Jørgensen M; Jensen T; Resuli M; Hansen PM; Christensen KB; Holst JJ; Hornum M; Feldt-Rasmussen B
    BMJ Open; 2013; 3(4):. PubMed ID: 23624993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
    Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
    J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A series of N-of-1 trials to assess the therapeutic interchangeability of two enalapril formulations in the treatment of hypertension in Addis Ababa, Ethiopia: study protocol for a randomized controlled trial.
    Alemayehu C; Mitchell G; Aseffa A; Clavarino A; McGree J; Nikles J
    Trials; 2017 Oct; 18(1):470. PubMed ID: 29017595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Left ventricular dysfunction in normotensive Type 1 diabetic patients: the impact of autonomic neuropathy.
    Taskiran M; Rasmussen V; Rasmussen B; Fritz-Hansen T; Larsson HB; Jensen GB; Hilsted J
    Diabet Med; 2004 Jun; 21(6):524-30. PubMed ID: 15154934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double-blind, crossover study of Doxazosin and Enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea patients.
    Zou D; Grote L; Eder DN; Radlinski J; Hedner J
    Sleep Med; 2010 Mar; 11(3):325-8. PubMed ID: 20171140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.
    Anholm C; Kumarathurai P; Klit MS; Kristiansen OP; Nielsen OW; Ladelund S; Madsbad S; Sajadieh A; Haugaard SB;
    BMJ Open; 2014 Jul; 4(7):e005942. PubMed ID: 25031198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
    Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
    Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist--protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol.
    Ishøy PL; Knop FK; Broberg BV; Baandrup L; Fagerlund B; Jørgensen NR; Andersen UB; Rostrup E; Glenthøj BY; Ebdrup BH
    BMJ Open; 2014 Jan; 4(1):e004158. PubMed ID: 24401727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension.
    Wells T; Frame V; Soffer B; Shaw W; Zhang Z; Herrera P; Shahinfar S;
    J Clin Pharmacol; 2002 Aug; 42(8):870-80. PubMed ID: 12162469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study.
    Marre M; Puig JG; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion Júnior D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Gallois Y; Amouyel P; Ollivier JP; Asmar R
    J Hypertens; 2004 Aug; 22(8):1613-22. PubMed ID: 15257186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients.
    Nishimura M; Hashimoto T; Kobayashi H; Fukuda T; Okino K; Yamamoto N; Nakamura N; Yoshikawa T; Takahashi H; Ono T
    Nephrol Dial Transplant; 2004 Oct; 19(10):2532-8. PubMed ID: 15252162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
    Havranek EP; Esler A; Estacio RO; Mehler PS; Schrier RW;
    Am Heart J; 2003 Jun; 145(6):993-8. PubMed ID: 12796754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial.
    Thirumathyam R; Richter EA; Goetze JP; Fenger M; Van Hall G; Dixen U; Holst JJ; Madsbad S; Vejlstrup N; Madsen PL; Jørgensen NB
    BMJ Open; 2022 Aug; 12(8):e054100. PubMed ID: 35953245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Management of hypertensive patients with left ventricular hypertrophy].
    Ambrosioni E
    Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nocturnal blood pressure non-dipping is not associated with increased left ventricular mass index in hypertensive children without end-stage renal failure.
    Seeman T; Hradský O; Gilík J
    Eur J Pediatr; 2016 Aug; 175(8):1091-7. PubMed ID: 27344339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protocol for assessing the hypotensive effect of evening administration of acetylsalicylic acid: study protocol for a randomized, cross-over controlled trial.
    Ruíz-Arzalluz MV; Fernández MC; Burgos-Alonso N; Vinyoles E; San Vicente Blanco R; Grandes G;
    Trials; 2013 Jul; 14():236. PubMed ID: 23890047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.